T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
T3D Therapeutics has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.
T3D Therapeutics's investors include National Institute on Aging.
T3D Therapeutics is headquartered in Durham, United States.
T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.
T3D Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"T3D Therapeutics — Funding & Investors." VCBacked, September 3, 2022, https://www.vcbacked.co/company/t3d-therapeutics. Accessed August 14, 2026.
VCBacked. (2022). T3D Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/t3d-therapeutics
{{cite web |title=T3D Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/t3d-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated